Bright Minds Biosciences Inc. (DRUG)

Bright Minds Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 18, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	769	429	5	6	20	85
Market Cap Growth	149.90%	8742.00%	-18.98%	-70.74%	-75.79%	-
Enterprise Value	547	393	0	0	14	67
Last Close Price	79.48	60.66	1.17	1.60	6.15	35.71
PB Ratio	3.55	7.29	1.19	1.23	2.67	5.51
P/TBV Ratio	3.55	7.29	1.19	1.23	2.67	5.52
Debt / Equity Ratio	0	0.00	0.02	0.01	0.01	-
Net Debt / Equity Ratio	-1.00	-1.01	-1.01	-1.01	-1.09	-1.02
Quick Ratio	121.44	35.68	10.92	24.16	8.00	31.12
Current Ratio	121.97	36.10	11.32	24.26	8.11	31.38
Return on Equity (ROE)	-13.63%	-27.93%	-46.18%	-86.02%	-99.95%	-85.94%
Return on Assets (ROA)	-13.50%	-18.80%	-25.28%	-47.45%	-57.32%	-51.52%
Return on Capital Employed (ROCE)	-12.70%	-16.60%	-47.10%	-109.10%	-138.80%	-44.40%
Earnings Yield	-2.24%	-2.04%	-42.70%	-90.90%	-53.20%	-8.09%
Buyback Yield / Dilution	-38.94%	-59.58%	-15.87%	-50.58%	-37.64%	-148.42%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error